NCT04310020 2026-03-17
Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
AstraZeneca
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Proton Collaborative Group
Massachusetts General Hospital